Global Oncology Information Systems Industry
Global Oncology Information Systems Market to Reach $3. 1 Billion by 2027. Amid the COVID-19 crisis, the global market for Oncology Information Systems estimated at US$1. 9 Billion in the year 2020, is projected to reach a revised size of US$3.
New York, Jan. 18, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Oncology Information Systems Industry” – https://www.reportlinker.com/p05957564/?utm_source=GNW
1 Billion by 2027, growing at aCAGR of 7% over the period 2020-2027. Software, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 6.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $565.6 Million, While China is Forecast to Grow at 6.5% CAGR
The Oncology Information Systems market in the U.S. is estimated at US$565.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$537.4 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.We bring years of research experience to this 6th edition of our report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Accuray, Inc.
- Cerner Corporation
- Elekta AB
- Epic Systems Corporation
- Flatiron Health, Inc.
- Koninklijke Philips NV
- McKesson Corporation
- RAYSEARCH Laboratories AB
- Varian Medical Systems, Inc.
Read the full report: https://www.reportlinker.com/p05957564/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Oncology Information System Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Oncology
Information Systems by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027
Table 2: World Historic Review for Oncology Information Systems
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 3: World 15-Year Perspective for Oncology Information
Systems by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Software by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027
Table 5: World Historic Review for Software by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019
Table 6: World 15-Year Perspective for Software by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 7: World Current & Future Analysis for Services by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027
Table 8: World Historic Review for Services by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019
Table 9: World 15-Year Perspective for Services by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 10: World Current & Future Analysis for Radiation
Oncology by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027
Table 11: World Historic Review for Radiation Oncology by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 12: World 15-Year Perspective for Radiation Oncology by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Medical Oncology
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027
Table 14: World Historic Review for Medical Oncology by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 15: World 15-Year Perspective for Medical Oncology by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Surgical Oncology
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027
Table 17: World Historic Review for Surgical Oncology by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
Table 18: World 15-Year Perspective for Surgical Oncology by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Oncology Information System Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 19: USA Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 20: USA Historic Review for Oncology Information Systems
by Segment – Software and Services Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019
Table 21: USA 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 22: USA Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 23: USA Historic Review for Oncology Information Systems
by Application – Radiation Oncology, Medical Oncology and
Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 24: USA 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
CANADA
Table 25: Canada Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 26: Canada Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 27: Canada 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 28: Canada Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 29: Canada Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 30: Canada 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
JAPAN
Table 31: Japan Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 32: Japan Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 33: Japan 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 34: Japan Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 35: Japan Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 36: Japan 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
CHINA
Table 37: China Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 38: China Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 39: China 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 40: China Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 41: China Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 42: China 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
European Oncology Information System Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 43: Europe Current & Future Analysis for Oncology
Information Systems by Geographic Region – France, Germany,
Italy, UK and Rest of Europe Markets – Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027
Table 44: Europe Historic Review for Oncology Information
Systems by Geographic Region – France, Germany, Italy, UK and
Rest of Europe Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019
Table 45: Europe 15-Year Perspective for Oncology Information
Systems by Geographic Region – Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027
Table 46: Europe Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 47: Europe Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 48: Europe 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 49: Europe Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 50: Europe Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 51: Europe 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
FRANCE
Table 52: France Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 53: France Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 54: France 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 55: France Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 56: France Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 57: France 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
GERMA¬NY
Table 58: Germany Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 59: Germany Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 60: Germany 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 61: Germany Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 62: Germany Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 63: Germany 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
ITALY
Table 64: Italy Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 65: Italy Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 66: Italy 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 67: Italy Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 68: Italy Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 69: Italy 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 70: UK Current & Future Analysis for Oncology Information
Systems by Segment – Software and Services – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027
Table 71: UK Historic Review for Oncology Information Systems
by Segment – Software and Services Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019
Table 72: UK 15-Year Perspective for Oncology Information
Systems by Segment – Percentage Breakdown of Value Sales for
Software and Services for the Years 2012, 2020 & 2027
Table 73: UK Current & Future Analysis for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027
Table 74: UK Historic Review for Oncology Information Systems
by Application – Radiation Oncology, Medical Oncology and
Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 75: UK 15-Year Perspective for Oncology Information
Systems by Application – Percentage Breakdown of Value Sales
for Radiation Oncology, Medical Oncology and Surgical Oncology
for the Years 2012, 2020 & 2027
REST OF EUROPE
Table 76: Rest of Europe Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 77: Rest of Europe Historic Review for Oncology
Information Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019
Table 78: Rest of Europe 15-Year Perspective for Oncology
Information Systems by Segment – Percentage Breakdown of Value
Sales for Software and Services for the Years 2012, 2020 & 2027
Table 79: Rest of Europe Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 80: Rest of Europe Historic Review for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019
Table 81: Rest of Europe 15-Year Perspective for Oncology
Information Systems by Application – Percentage Breakdown of
Value Sales for Radiation Oncology, Medical Oncology and
Surgical Oncology for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Table 82: Asia-Pacific Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 83: Asia-Pacific Historic Review for Oncology Information
Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019
Table 84: Asia-Pacific 15-Year Perspective for Oncology
Information Systems by Segment – Percentage Breakdown of Value
Sales for Software and Services for the Years 2012, 2020 & 2027
Table 85: Asia-Pacific Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 86: Asia-Pacific Historic Review for Oncology Information
Systems by Application – Radiation Oncology, Medical Oncology
and Surgical Oncology Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019
Table 87: Asia-Pacific 15-Year Perspective for Oncology
Information Systems by Application – Percentage Breakdown of
Value Sales for Radiation Oncology, Medical Oncology and
Surgical Oncology for the Years 2012, 2020 & 2027
REST OF WORLD
Table 88: Rest of World Current & Future Analysis for Oncology
Information Systems by Segment – Software and Services –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027
Table 89: Rest of World Historic Review for Oncology
Information Systems by Segment – Software and Services Markets –
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019
Table 90: Rest of World 15-Year Perspective for Oncology
Information Systems by Segment – Percentage Breakdown of Value
Sales for Software and Services for the Years 2012, 2020 & 2027
Table 91: Rest of World Current & Future Analysis for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology – Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
Table 92: Rest of World Historic Review for Oncology
Information Systems by Application – Radiation Oncology,
Medical Oncology and Surgical Oncology Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019
Table 93: Rest of World 15-Year Perspective for Oncology
Information Systems by Application – Percentage Breakdown of
Value Sales for Radiation Oncology, Medical Oncology and
Surgical Oncology for the Years 2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 43
Read the full report: https://www.reportlinker.com/p05957564/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
